Håkan Hallberg has successfully led Takura since its foundation to today’s position as a biocell portfolio development company active in both mesenchymal stromal cells (MSC) and immuno oncology (TIL). Approaching retirement, Håkan now hands over the responsibility as CEO of Takura to Jonas Båtelson.
Jonas was engaged as consultant during the spring to support the work with Takura’s future development plan. He brings extensive experience from healthcare and life sciences from his previous roles in management consulting. He has also acted in various management and leadership positions in the technology and professional services sectors.
16th of August, 2022